Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ravenbhel Healthcare is an Indian pharmaceutical company focused on formulation development, contract development and manufacturing, and commercial marketing of pharmaceutical and nutraceutical products. The company was established in 2003 and operates as a privately held manufacturer of finished dosage formulations for domestic and international markets. Its manufacturing footprint includes WHO-GMP-certified facilities producing tablets, capsules, oral liquids, sachets, and reportedly additional capabilities spanning non-sterile dosage forms, packaging, regulatory support, and some injectable and clinical-dose services. Ravenbhel positions itself as a dependable formulation partner for national and multinational pharma companies, with customer references in external directories including Abbott, Sun, Cipla, IPCA, Novartis, and Ranbaxy. The business appears to be primarily a commercial-stage pharma manufacturing and CDMO-style services company rather than a novel therapeutics developer with a disclosed clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ravenbhel Healthcare.